Forex ziņas
U.S. Stocks Close On Upbeat Note
After opening with a positive gap, U.S. stocks kept moving higher and higher on Monday as buying gathered momentum and finally ended the session on a buoyant note.
RTTNews |
834 days ago
Swiss Market Ends Marginally Up
After plunging sharply early on in the session on Monday, the Switzerland stock market recovered slowly on bargain hunting and emerged into positive territory in the final hour to eventually close modestly higher.
RTTNews
|
834 days ago
European Markets Close Higher On Hectic Bargain Hunting In The Final Hour
After languishing in the red till well past noon on Monday, European Stocks rallied on hectic buying in the final hour to eventually close on a positive note.
RTTNews
|
834 days ago
Canadian Stocks Rising Sharply On All-round Buying
The Canadian market is up sharply in positive territory a little past noon on Monday, with stocks extending morning gains thanks to sustained buying interest.
RTTNews
|
834 days ago
U.S. Construction Spending Decreases More Than Expected In August
A report released by the Commerce Department on Monday showed construction spending in the U.S. decreased by more than expected in the month of August. The Commerce Department said construction spending fell by 0.7 percent to an annual rate of $1.781 trillion in August after sliding by 0.6 percent to a revised rate of $1.794 trillion in July.
RTTNews
|
834 days ago
U.S. Manufacturing Index Dips More Than Expected But Still Indicates Growth
Activity in the U.S. manufacturing sector slowed by more than expected in the month of September but still saw continued growth, according to a report released by the Institute for Supply Management on Monday.
RTTNews
|
834 days ago
Gilead Company Kite Says FDA Oks RVV Manufacturing Facility In California For Commercial Production
Biopharmaceutical company Kite, a Gilead Sciences, Inc. (GILD) company, announced Monday that the U.S. Food and Drug Administration (FDA) has approved the company's retroviral vector (RVV) manufacturing facility in Oceanside, California, for commercial production.
RTTNews
|
834 days ago
more news
Hyundai Motor America September Total Sales Up 11%
Hyundai Motor America reported Monday that it sold a total of 59,465 units in the month of September, up 11 percent from last year's 53,800 units, driven by new September sales records for Elantra HEV, IONIQ 5, Santa Cruz, Santa Fe HEV, Tucson, Tucson PHEV and Veloster N. Hyundai achieved an all-time September retail sales record.
RTTNews
|
834 days ago
Viasat To Sell Link 16 Tactical Data Links Business To L3Harris For $1.96 Bln
Viasat Inc. (VSAT), a global leader in satellite communications, announced Monday it has entered into a definitive agreement to sell its Link 16 Tactical Data Links (TDL) business to L3Harris Technologies, Inc. (LHX) for $1.96 billion, subject to customary transaction adjustments in accordance with the agreement.
RTTNews
|
834 days ago
Pound Climbs As U.K. Abandons Plan To Cut Top Tax Rate
The pound gained ground against its major counterparts in the European session on Monday, as the U.K. government has decided to drop a plan to ditch the top rate of income tax following severe criticism and turmoil on financial markets.
RTTNews
|
834 days ago
Bay Street Likely To Open On Firm Note
Canadian shares are likely to open on a positive note on Monday, tracking sharply higher crude oil prices.
RTTNews
|
835 days ago
UK Manufacturing Sector Shrinks In September
The UK manufacturing sector shrank again in September as companies cutback production amid falling orders, final survey data from S&P Global showed on Monday. The S&P Global/Chartered Institute of Procurement & Supply manufacturing Purchasing Managers' Index posted 48.4 in September, up from 47.3 in August.
RTTNews
|
835 days ago
RedHill Says Its Oral Antivirals, Opaganib And RHB-107, Inhibit Dominant Omicron Sub-Variant BA.5
Specialty biopharmaceutical company RedHill Biopharma Ltd. (RDHL) announced Monday the study results showing in vitro efficacy against the currently dominant Omicron COVID-19 sub-variant BA.5, by both of RedHill's novel, oral, host-directed and broad-acting investigational antivirals, once-daily RHB-107 (upamostat) and twice-daily opaganib.
RTTNews
|
835 days ago
Stay up to date!
Add News to your browser
Add To Chrome
